Ore Pharmaceuticals has appointed Benjamin Palleiko as senior vice president and chief financial officer. Palleiko will lead all corporate financial activities, as well as work with the rest of the management team to drive Ore’s strategy and growth. He will be based in Cambridge, MA.
Palleiko has lengthy industry experience as both a public pharmaceuticals company CFO and as an investment banker focused on the life sciences sector. Previously, he served as principal of Intrepid Merchant Partners, a healthcare advisory and investments firm he founded in March 2006. From June 2006 to January 2009, Palleiko was senior vice president, corporate development and CFO of Penwest Pharmaceuticals, a publicly held specialty pharmaceuticals company. From March 2003 to March 2006, he served as director, head of Life Sciences Investment Banking at Suntrust Robinson Humphrey, and from 2000 to 2002, he was vice president, Investment Banking at Robertson Stephens.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more